Jonathan Wardman is a Senior Scientist at Adcendo, specializing in non-clinical development and antibody-drug conjugates targeting cancer. They previously served as a Research Assistant Professor at Københavns Universitet from 2019 to 2023 and as a Postdoctoral Fellow at Rigshospitalet from 2014 to 2019, where they studied neurodegenerative diseases. Jonathan completed a PhD in Pharmacology at Albert Einstein College of Medicine in 2012, following a B.S. in Cell Biology and Aquatic Biology from the University of California, Santa Barbara. Their research background includes significant contributions to neuropeptide functions and therapeutic strategies for neurodegenerative diseases.
This person is not in the org chart
This person is not in any teams
This person is not in any offices